Sign in to view content

Short-term Oral Mifepristone for the Treatment of Central Serous Chorioretinopathy (STOMP-CSC): A Placebo-Controlled Clinical Trial

Roger A. Goldberg, MD, MBA

Video
Published 2018

Related

Real World Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
Carl J Danzig, MD
Updates from the Field
2022
Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks
Pauline T. Merrill, MD, FASRS
Annual Meeting Talks
2019
Patient-Centric Assessment of the Quality of Care Delivered in a Diabetic Retinopathy Teleretinal Screening Program
Christina Y Weng, MD, MBA, FASRS
Annual Meeting Talks
2018

Category: Imaging – Digital-Fluorescein angiography

See more